A Prospective Research Investigation of Ischemia Using MCG
Not yet recruiting
- Conditions
- Acute Coronary Syndrome
- Registration Number
- NCT06481943
- Lead Sponsor
- SB Technology, Inc.
- Brief Summary
PRISM is a prospective, pilot research study that aims to systematically characterize the usefulness of CardiAQ MCG, a bedside magnetocardiography device, in the evaluation of myocardial ischemia and infarction status.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- NOT_YET_RECRUITING
- Sex
- All
- Target Recruitment
- 150
Inclusion Criteria
- Scheduled to undergo a diagnostic angiography or revascularization procedure for the diagnosis or treatment of ischemia or acute myocardial infarction
- Ability for participant to comply with study requirements
- Patient consented before the planned, clinically indicated cath-lab procedure begins to allow sufficient time for study related activities
- Written informed consent
Exclusion Criteria
- Present STEMI
- Pregnant or breastfeeding
- Having an active atrial fibrillation episode as seen on most current 12-lead ECG
- Active thoracic metal implant
- Poor access to follow-up
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Relationship between pre-procedural MCG and the peri-procedural angiography-based measures Data taken within 24 hours of each other Utilize linear regression and logistic regression to determine whether a set of a priori MCG-based biomarkers can prospectively predict the objective clinical assessment of ACS, while statistically adjusting for covariates.
- Secondary Outcome Measures
Name Time Method Sponsor MCG device safety 30 days Device-related adverse events
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms does CardiAQ MCG use to detect myocardial ischemia in acute coronary syndrome patients?
How does magnetocardiography compare to ECG and cardiac MRI in diagnosing acute coronary syndrome?
What biomarkers are associated with myocardial infarction detection using CardiAQ MCG technology?
Are there any reported adverse events with the SandboxAQ MCG device in clinical evaluations?
What are the potential advantages of bedside MCG over traditional stress testing for ischemia detection?
Trial Locations
- Locations (1)
Mayo Clinic
🇺🇸Rochester, Minnesota, United States
Mayo Clinic🇺🇸Rochester, Minnesota, United StatesGhasaq Saleh, MDContact5072552504saleh.ghasaq@mayo.eduMohamad A Alkhouli, MD, MBAContact